ncRNA name
FENDRR
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
ABCB1/ABCC1
Cancer name
Osteosarcoma
Cancer site
Bone, Articular Cartilage
Treatment type
Chemotherapy
Drug
Doxorubicin
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
80
Male patients
58
Female patients
22
Age range and number
Not available
PMID
Description
Our study demonstrated that lncRNA FENDRR may act as an inhibitory molecule of doxorubicin-resistance through down-regulating the expression of ABCB1 and ABCC1 genes in osteosarcoma cells.
Tissue resource
osteosarcoma samples
human osteosarcoma cell lines SaoS2
human osteosarcoma cell lines HOS
human osteosarcoma cell lines MG63
Experiment
qRT-PCR,Western blot
Institute
Shanghai Tenth People's Hospital Affiliated to Tongji University
American Type Culture Collection
Country
China
USA
Continent
Asia
North American